Furthermore, 88.2% (n=15) of patients with prostatic adenocarcinoma in grades 7–10 showed positive overexpression of EMA protein, whereas 11.8% (n=2) exhibited negative expression, so there was a significant positive correlation between EMA protein expressions and the grade of the tumor (p=0.003) (Figure 4). Here, MUC1 is linked to prostate adenocarcinoma.